HLA typing for transplantation market to reach $1.7 billion by 2032, says Global Market Insights Inc.

Global Market Insight Inc.

The HLA typing for transplantation industry is projected to experience a CAGR of 8.5% between 2023 and 2032 due to the increase in the number of solid organ transplants.

Selbyville, Delaware, November 23, 2022 (GLOBE NEWSWIRE) —

HLA typing for transplantation market value is projected to reach $1.7 billion by 2032, according to a recent research report announced by Global Market Insights Inc.

Increasing Geriatric Patient Pool with Chronic Diseases Will Complement HLA Typing for Transplant Industry Prospects. Organ failure due to chronic disease is a major concern among the elderly population. With advances in technology, the success rate of organ transplant surgeries has increased dramatically in recent years. An increase in liver and kidney transplant procedures should drive the need for HLA typing.

Request a sample of this research report @ https://www.gminsights.com/request-sample/detail/1653

Need for affordable diagnosis and treatment to increase demand for non-molecular testing
HLA typing for transplantation market share from non-molecular testing technology surpassed $115 million in 2022. Non-molecular testing helps identify molecules responsible for immune rejection of incompatible grafts along with molecules expressed on the cell. Includes lymphocyte culture and serological testing. Serological tests are considered a better alternative to regular PCR-based tests as they are easier to perform and less expensive. Furthermore, non-molecular tests have low specificity and high sensitivity which allow for accurate detection.

Advances in personalized HLA typing and crossmatching services

The HLA typing for Transplantation Services market is projected to witness a CAGR greater than 7.5% from 2023 to 2032. HLA typing services include a broad range of offerings for diagnostics, registry typing, confirmation typing and validation and sending of the new allele. HLA antibody screening and lymphocyte crossmatching services improve transplant patient survival rate and complete remission rate. Large organizations and laboratories offer services tailored to the needs of their clients. While healthcare facilities provide a suite of services to ensure that compatible organ transplant surgeries are performed and other consequences are avoided.

Browse key industry information spread across 255 pages with 354 market data tables and 19 figures and charts from the report,” HLA Typing for Transplantation Market Size by Technology (Non-Molecular Assays [Serological Assays, Mixed Lymphocyte Culture Assay]Molecular essays [PCR Based Molecular Assays, Sequencing Based Molecular Assays {Sanger Sequencing, Next Generation Sequencing}]), by product and services (instruments, reagents and consumables, software, services), by application (diagnostics, research), by end use (hospitals, diagnostic laboratories, research and academic institutions), industry analysis report, Industry Analysis Report, Regional Outlook Growth Potential, Competitive Market Share and Forecast, 2023-2032in detail along with the table of contents:


Robust investment and funding to accelerate research and development for improved HLA typing tests for transplants

HLA typing for transplantation market from research application is predicted to exhibit a CAGR above 8.5% by 2032. Extensive research and development (R&D) efforts are being made to focus on the introduction of typing testing New generation HLA related to organ transplantation. The researchers took a statistical approach that uses higher quality HLA data to minimize the ambiguity associated with poor quality datasets. A large number of public and private organizations are investing in the advancement and innovation of HLA typing testing.

Increased stem cell transplants to increase HLA typing in Europe for the transplant industry

The European HLA typing for transplantation market will exceed $575 million by 2032. The growing number of organ and stem cell transplant surgeries across the region will be a key factor in boosting the growth of the industry. The region is also expected to see high stem cell transplant activity which should accelerate the need for HLA typing tests. In the UK alone, nearly 4,000 stem cell or bone marrow transplants are performed each year.

Request for customization of this research report @ https://www.gminsights.com/roc/1653

New Product Innovations to Enhance HLA Typing for Expanding Transplant Industry

Abbott Laboratories, Bio-Rad Laboratories, CareDx, Luminex Corporation, BioReference Laboratories, GenDx, Illumina Inc., Immucor Inc., Inno-train Diagnostik GmbH, Omixon, Inc., Pacific Biosciences of California, Inc, Qiagen NV, F. Hoffmann -La Roche Ltd, Thermo-Fisher Scientific Inc., Fujirebio, BAG Diagnostic GmbH, GMSbiotech, Inc., Biofortuna Limited, TBG Diagnostics Limited are some of the leading companies in the global market of HLA typing for transplantation.

Browse our Report Shop – GMIPulse @ https://www.gminsights.com/gmipulse

Information on global markets

Global Market Insights Inc., headquartered in Delaware, United States, is a global market research and advisory services provider, offering syndicated and custom market research reports along with growth advisory services. Our business intelligence and industry research reports provide clients with in-depth insights and actionable market data specially designed and presented to aid strategic decision making. These comprehensive reports are designed using a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

CONTACT: Contact Us: Aashit Tiwari Corporate Sales, USA Global Market Insights Inc. Toll Free: +1-888-689-0688 USA: +1-302-846-7766 Europe: +44-742-759-8484 APAC: +65-3129-7718 Email: sales@gminsights.com Read More News @ https://ibmag.com/     

Leave a Reply

%d bloggers like this: